The company's investigational drug, Telomir-1, showed potential in treating progeria, a rare genetic condition characterized by accelerated aging in children. In addition, it demonstrated ...

Progeria is an autosomal recessive disorder ... the heterozygous parents can be distinguished from normals by decreased cell growth in culture. Mitotic activity, DNA synthesis, and cloning ...

Telomir Pharmaceuticals , Inc. (NASDAQ:TELO), a $141 million market cap biopharmaceutical company engaged in age-reversal science, has announced significant preclinical study results today, indicating ...

A comprehensive atlas of the human hypothalamus, a brain region that regulates many bodily functions, including temperature, sleep and appetite, has been built using single-cell RNA sequencing and ...

Ubisoft is apparently endeavoring to work with Tencent to bring forth new ventures, one of which is the rumored Splinter Cell Remake. During an address, Guillemot confirmed numerous titles were in ...

In 2009 a team of biophysicists led by Anthony A. Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, were studying specklelike structures called P ...

A recent study from Tata Institute of Fundamental Research, Mumbai, India has revealed new details about how our cells clean up and recycle waste. This process, known as autophagy, is like a self ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

The proteins that make cell-to-cell cargo transport possible. ScienceDaily . Retrieved February 8, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250115165210.htm ...